U.S. flag

An official website of the United States government

NM_000390.4(CHM):c.130G>T (p.Gly44Ter) AND not provided

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Dec 25, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000259262.2

Allele description [Variation Report for NM_000390.4(CHM):c.130G>T (p.Gly44Ter)]

NM_000390.4(CHM):c.130G>T (p.Gly44Ter)

Gene:
CHM:CHM Rab escort protein [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xq21.2
Genomic location:
Preferred name:
NM_000390.4(CHM):c.130G>T (p.Gly44Ter)
HGVS:
  • NC_000023.11:g.85981796C>A
  • NG_009874.2:g.70767G>T
  • NM_000390.3:c.130G>T
  • NM_000390.4:c.130G>TMANE SELECT
  • NM_001145414.4:c.130G>T
  • NM_001320959.1:c.-315G>T
  • NM_001362517.1:c.-315G>T
  • NM_001362518.2:c.-311G>T
  • NM_001362519.1:c.-311G>T
  • NP_000381.1:p.Gly44Ter
  • NP_001138886.1:p.Gly44Ter
  • LRG_699t1:c.130G>T
  • LRG_699:g.70767G>T
  • NC_000023.10:g.85236800C>A
  • NM_000390.2:c.130G>T
Protein change:
G44*
Links:
dbSNP: rs886041175
NCBI 1000 Genomes Browser:
rs886041175
Molecular consequence:
  • NM_001320959.1:c.-315G>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001362517.1:c.-315G>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001362518.2:c.-311G>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001362519.1:c.-311G>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_000390.4:c.130G>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001145414.4:c.130G>T - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000329289GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Pathogenic
(Aug 17, 2016)
germlineclinical testing

Citation Link,

SCV004300135Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Dec 25, 2023)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Molecular basis of choroideremia (CHM): mutations involving the Rab escort protein-1 (REP-1) gene.

van den Hurk JA, Schwartz M, van Bokhoven H, van de Pol TJ, Bogerd L, Pinckers AJ, Bleeker-Wagemakers EM, Pawlowitzki IH, RĂ¼ther K, Ropers HH, Cremers FP.

Hum Mutat. 1997;9(2):110-7. Review.

PubMed [citation]
PMID:
9067750

A clinical molecular genetic service for United Kingdom families with choroideraemia.

Ramsden SC, O'Grady A, Fletcher T, O'Sullivan J, Hart-Holden N, Barton SJ, Hall G, Moore AT, Webster AR, Black GC.

Eur J Med Genet. 2013 Aug;56(8):432-8. doi: 10.1016/j.ejmg.2013.06.003. Epub 2013 Jun 25.

PubMed [citation]
PMID:
23811034
See all PubMed Citations (5)

Details of each submission

From GeneDx, SCV000329289.6

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The G44X nonsense variant, also reported as c.160 G>T using alternative nomenclature, in the CHM gene has been reported previously in association with choroideremia and was shown to result in complete lack of CHM protein expression in leukocytes (Zhang et al., 2015; McTaggart et al., 2002). This pathogenic variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. Additionally the G44X variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI ExomeSequencing Project, indicating it is not a common benign variant in these populations. Therefore, the G44X variant is interpreted as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Invitae, SCV004300135.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

This sequence change creates a premature translational stop signal (p.Gly44*) in the CHM gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CHM are known to be pathogenic (PMID: 9067750, 23811034). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with choroideremia (PMID: 12203991, 30297895). This variant is also known as c.160G>T. ClinVar contains an entry for this variant (Variation ID: 279771). For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 12, 2024